Elicio Therapeutics, Inc. Common Stock (ELTX) is a publicly traded Healthcare sector company. As of July 28, 2026, ELTX trades at $3.04 with a market cap of $78.79M and a P/E ratio of -1.17. ELTX moved +0.00% today. Year to date, ELTX is -62.31%; over the trailing twelve months it is -69.67%. Its 52-week range spans $2.66 to $16.00. Analyst consensus is strong buy with an average price target of $20.67. Rallies surfaces ELTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for ELTX, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $3.04 |
| Market Cap | $78.79M |
| P/E Ratio | -1.17 |
| EPS | $-2.58 |
| Dividend Yield | 0.00% |
| 52-Week High | $16.00 |
| 52-Week Low | $2.66 |
| Volume | 186.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-39.57M |
| Gross Margin | 0.00% |
4 analysts cover ELTX: 0 strong buy, 3 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $20.67.